Literature DB >> 17013562

Melanoma cells exhibit strong intracellular TASK-3-specific immunopositivity in both tissue sections and cell culture.

K Pocsai1, L Kosztka, G Bakondi, M Gönczi, J Fodor, B Dienes, P Szentesi, I Kovács, R Feniger-Barish, E Kopf, D Zharhary, G Szucs, L Csernoch, Z Rusznák.   

Abstract

Amplification of the kcnk9 gene and overexpression of the encoded channel protein (TASK-3) seems to be involved in carcinogenesis. In the present work, TASK-3 expression of melanoma cells has been studied. For the investigation of TASK-3-specific immunolabelling, a monoclonal antibody has been developed and applied along with two, commercially available polyclonal antibodies targeting different epitopes of the channel protein. Both primary and metastatic melanoma cells proved to be TASK-3 positive, showing prominent intracellular TASK-3-specific labelling; mostly concentrating around or in the proximity of the nuclei. The immunoreaction was associated with the nuclear envelope, and with the processes of the cells and it was also present in the cell surface membrane. Specificity of the immunolabelling was confirmed by Western blot and transfection experiments. As TASK-3 immunopositivity of benign melanocytes could also be demonstrated, the presence or absence of TASK-3 channels cannot differentiate between malignant and non-malignant melanocytic tumours.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17013562     DOI: 10.1007/s00018-006-6166-8

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  14 in total

1.  Mitochondrial expression of the two-pore domain TASK-3 channels in malignantly transformed and non-malignant human cells.

Authors:  Zoltán Rusznák; Gábor Bakondi; Lívia Kosztka; Krisztina Pocsai; Beatrix Dienes; János Fodor; Andrea Telek; Mónika Gönczi; Géza Szucs; László Csernoch
Journal:  Virchows Arch       Date:  2007-12-20       Impact factor: 4.064

2.  TASK3 and its role in neuro and systemic oncogenesis.

Authors:  Shailendra Kapoor
Journal:  J Neurooncol       Date:  2008-06       Impact factor: 4.130

3.  Potassium channel in the mitochondria of human keratinocytes.

Authors:  Renata Toczyłowska-Mamińska; Anna Olszewska; Michał Laskowski; Piotr Bednarczyk; Krzysztof Skowronek; Adam Szewczyk
Journal:  J Invest Dermatol       Date:  2013-10-14       Impact factor: 8.551

Review 4.  Pharmacological modulation of mitochondrial ion channels.

Authors:  Luigi Leanza; Vanessa Checchetto; Lucia Biasutto; Andrea Rossa; Roberto Costa; Magdalena Bachmann; Mario Zoratti; Ildiko Szabo
Journal:  Br J Pharmacol       Date:  2019-01-02       Impact factor: 8.739

5.  Acid sensitive background potassium channels K2P3.1 and K2P9.1 undergo rapid dynamin-dependent endocytosis.

Authors:  Alexandra Mant; Sarah Williams; Ita O'Kelly
Journal:  Channels (Austin)       Date:  2013-06-10       Impact factor: 2.581

6.  Altered expression of two-pore domain potassium (K2P) channels in cancer.

Authors:  Sarah Williams; Andrew Bateman; Ita O'Kelly
Journal:  PLoS One       Date:  2013-10-07       Impact factor: 3.240

7.  TASK-3 Downregulation Triggers Cellular Senescence and Growth Inhibition in Breast Cancer Cell Lines.

Authors:  Rafael Zúñiga; Claudio Valenzuela; Guierdy Concha; Nelson Brown; Leandro Zúñiga
Journal:  Int J Mol Sci       Date:  2018-03-29       Impact factor: 5.923

8.  TASK-1 Regulates Apoptosis and Proliferation in a Subset of Non-Small Cell Lung Cancers.

Authors:  Katharina Leithner; Birgit Hirschmugl; Yingji Li; Bi Tang; Rita Papp; Chandran Nagaraj; Elvira Stacher; Philipp Stiegler; Jörg Lindenmann; Andrea Olschewski; Horst Olschewski; Andelko Hrzenjak
Journal:  PLoS One       Date:  2016-06-13       Impact factor: 3.240

Review 9.  Impact of intracellular ion channels on cancer development and progression.

Authors:  Roberta Peruzzo; Lucia Biasutto; Ildikò Szabò; Luigi Leanza
Journal:  Eur Biophys J       Date:  2016-06-11       Impact factor: 1.733

Review 10.  Membrane Transporters and Channels in Melanoma.

Authors:  Ines Böhme; Roland Schönherr; Jürgen Eberle; Anja Katrin Bosserhoff
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.